Deadly microbe dodges human immune system

by Dr Tim Barnett
Deadly microbe dodges human immune system
Group A Streptococcus (green) shown to be growing inside of a cell (red, caputured by a fluorescence microscope).

Scientists from The University of Queensland have discovered that a microbe responsible for invasive bacterial Group A Streptococcus infections can bypass the immune system and multiply within infected cells.

Group A Streptococcus is one of the world's most fatal , with 600,000 cases annually.

In December last year a statewide alert was issued to all doctors and hospitals after a four-year-old child died from Group A Streptococcal disease in Brisbane.

Research leader Dr Tim Barnett from UQ's School of Chemistry and Molecular Biosciences said the findings were significant because they contradicted previous understandings of how the bacteria behaved.

"We studied M1T1, one of the most prevalent strains affecting the developed world," Dr Barnett said.

"It had previously been thought that autophagy, which is part of the , efficiently defended the interior of cells against Group A Streptococcus."

He said the research showed that in fact M1T1 produced an enzyme that breaks down the patient's immune proteins that fight bacterial infection.

"Our findings were vastly different to previous studies that used strains not commonly associated with human disease," Dr Barnett said.

"We now know that Streptococcus can hide, survive and grow in cells."

Dr Barnett is part of Professor Mark Walker's research group.

He and other colleagues at the Australian Infectious Diseases Research Centre are using this discovery to continue investigations in the field.

The research is also relevant to a number of types of Group A Streptococcus, including M12 strain found in a recent outbreak of scarlet fever in Hong Kong.

More information: Timothy C. Barnett, David Liebl, Lisa M. Seymour, Christine M. Gillen, Jin Yan Lim, Christopher N. LaRock, Mark R. Davies, Benjamin L. Schulz, Victor Nizet, Rohan D. Teasdale, Mark J. Walker, "The Globally Disseminated M1T1 Clone of Group A Streptococcus Evades Autophagy for Intracellular Replication," Cell Host & Microbe, Volume 14, Issue 6, 11 December 2013, Pages 675-682, ISSN 1931-3128, dx.doi.org/10.1016/j.chom.2013.11.003.

Related Stories

Scientists reveal steps leading to necrotizing fasciitis

Jan 16, 2014

How does Streptococcus pyogenes, or Group A streptococcus (GAS)—a bacterial pathogen that can colonize humans without causing symptoms or can lead to mild infections—also cause life-threatening diseas ...

Typhoid Fever: A race against time

Jan 16, 2014

The life-threatening disease typhoid fever results from the ongoing battle between the bacterial pathogen Salmonella and the immune cells of the body. Prof. Dirk Bumann's research group at the Biozentrum ...

Strep infections responsible for groper deaths

Jul 20, 2011

Researchers are in a race against time to save Queensland's protected groper fish, which are washing up dead along the beaches of Northern Queensland in increasing numbers.

Genome blueprint for horse and human vaccines

Jul 14, 2011

Two strains of Streptococcus bacteria, that have evolved to cause potentially fatal infections in either horses or humans, use the same box of tricks to cause disease. Exploiting their genetic similarities could ...

Recommended for you

Poll: Many doubt hospitals can handle Ebola

47 minutes ago

A new poll finds most Americans have some confidence that the U.S. health care system will prevent Ebola from spreading in this country, but they're not so sure their local hospital can safely handle a patient.

Number of Ebola cases nears 10,000

1 hour ago

The number of people with Ebola is set to hit 10,000 in West Africa, the World Health Organization said, as the scramble to find a cure gathered pace.

'Breath test' shows promise for diagnosing fungal pneumonia

1 hour ago

Many different microbes can cause pneumonia, and treatment may be delayed or off target if doctors cannot tell which bug is the culprit. A novel approach—analyzing a patient's breath for key chemical compounds made by the ...

Where Ebola battles are won

10 hours ago

(HealthDay)—Four hospitals that are home to advanced biocontainment facilities have become America's ground zero in the treatment of Ebola patients.

User comments